AFCM
RPRX icon

Applied Finance Capital Management’s Royalty Pharma RPRX Stock Holding History

Applied Finance Capital Management’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-11,265
Closed -$351K – 361
2025
Q1 		$351K Buy
11,265
+329
+3% +$10.4K 0.03% 228
2024
Q4 		$279K Hold
10,936
– – 0.01% 255
2024
Q3 		$309K Sell
10,936
-1,956
-15% -$54.2K 0.01% 249
2024
Q2 		$340K Buy
+12,892
New +$357K 0.02% 239

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CIA
Caledonia Investments (Australia) Sydney NSW, Australia $3.44B AUM 20.03% 1-Year Est. Return

Applied Finance Capital Management's RPRX Position: Q2 2025 in Review

Applied Finance Capital Management sold out of Royalty Pharma (RPRX) in Q2 2025, closing a stake of 11,265 shares — an estimated $351K sold.

Applied Finance Capital Management first reported a position in RPRX in Q2 2024 and held it in 4 quarters. The position peaked at $351K in Q1 2025. 455 funds tracked by Wall St. Rank hold RPRX as of Q2 2025.

  • Applied Finance Capital Management reported no remaining Royalty Pharma position as of Q2 2025 after selling out during the quarter.
  • Applied Finance Capital Management sold 11,265 Royalty Pharma shares in Q2 2025, an estimated $351K.
  • Applied Finance Capital Management first reported a position in Royalty Pharma in Q2 2024 and held it in 4 quarters.
  • Applied Finance Capital Management's Royalty Pharma position peaked at $351K in Q1 2025.
  • 455 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2025.

Based on Applied Finance Capital Management's 13F filing for Q2 2025, filed 29 Jul 2025.